Signal transduction inhibitors in treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis that results in reduced blood counts. Although MDS can transform into leukemia, most of the morbidity experienced by these patients is due to chronically low blood counts. Conventional cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachegowda, Lohith, Gligich, Oleg, Mantzaris, Ionnis, Schinke, Carolina, Wyville, Dale, Carrillo, Tatiana, Braunschweig, Ira, Steidl, Ulrich, Verma, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716523/
https://www.ncbi.nlm.nih.gov/pubmed/23841999
http://dx.doi.org/10.1186/1756-8722-6-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716523/
https://www.ncbi.nlm.nih.gov/pubmed/23841999
http://dx.doi.org/10.1186/1756-8722-6-50

Ejemplares similares